AI in the healthcare industry is not new. It's evolved from very early clinical decision support to predictive analysis, to digital diagnostics, and is now also building generative tools for documentation and patient communication. Diagnosis plus care, plus actual medication and therapy, is what really treats the patient.AI in the healthcare industry is not new. It's evolved from very early clinical decision support to predictive analysis, to digital diagnostics, and is now also building generative tools for documentation and patient communication. Diagnosis plus care, plus actual medication and therapy, is what really treats the patient.

AI Has Changed How We Diagnose, Not How We Deliver

2025/10/30 13:00
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

It has been a decade of intelligence. Every new day, something new comes in that is revolutionizing healthcare and healthtech as a whole. And AI in the healthcare industry it's not new. It's evolved from very early clinical decision support to predictive analysis, to digital diagnostics, and is now also building generative tools for documentation and patient communication.

There is EHR automation, radiology, and even predictive modeling. We have built intelligence to predict outcomes, code charts, but not deliver what patients need when they need it. That is the real challenge that health tech AI has right now. It comes across as a smarter algorithm, but all it is is just a smarter enablement.

But in reality, what actually happens in today's system of healthtech?

So, assume a patient goes to a doctor with some sort of symptoms. The doctor examines them, diagnoses them using all “next gen” intelligence and generative AI tools, and they get diagnosed. It turns out that they have a chronic disorder. AI and tech have helped us find and identify the problem.

But what happens after that? What happens after a diagnosis is made? When a prescription is written, or when a therapy is recommended, or when an intervention is needed for that patient? Just the diagnosis is not going to treat the patient. Diagnosis plus care, plus actual medication and therapy, is what really treats the patient.

Roughly 20–30% of prescriptions are never filled. That radically increases the chances of re-hospitalization, conditions getting worse, or patients completely dropping out of treatments. A big part of this is caused due to missing links in the supply chain, the weak link that becomes incredibly costly and damaging when it breaks. Cold chain failures alone cost more than $35 billion globally every year.

Even though through all the diagnoses, all the AI, and all the tech were used, just treating the patient is not about the diagnosis. This is a system design failure, not a logistical one. It's disjointed data, no visibility from the provider, pharmacy, and limited patient-side intelligence, all turn into a design failure. AI models stop at the EHR boundary; they optimize clinical flow, but not operational execution. And that leads to the delivery chain lagging in interoperability and real-time feedback loops.

We have digitized diagnosis, but left the delivery analog.

Why Last-Mile Intelligence Matters

Everybody is concerned about the bigger picture, but let's look at the micro picture. One delayed medication, one delayed therapy for MS or cancer, can trigger re-admission or treatment restart. Every undelivered refrigerated medication becomes silent data losses that go untracked, unreported, and unprevented.

It may seem like one-off events that happen, but all of them contribute to a bigger operational failure that exists in healthcare and health tech. That’s why we need last-mile intelligence and last-mile care.

When I think of it, I think of it as a concept of operational intelligence and care using the same AI frameworks that we already use: prediction, pattern recognition, automation, algorithms, but applying them also to movement, temperature, timing, and patient readiness. When a delivery is so clinical, logistics also become part of the care. And that’s what an actual end-to-end health tech system needs to build: a closed loop that healthcare needs to complete.

What This Care Intelligence Would Look Like

Let’s imagine a very near-future architecture:

  • Predictive routing that adjusts delivery based on a patient’s schedule and climate conditions. This helps patients know when their medications are coming and how they are going to be stored.
  • AI-focused inventory forecasting that prevents waste and cold-chain failures, saving billions for both patients and providers.
  • Transparent, context-driven notifications, not just tracking links, giving patients the right information and pharmacies the right instructions so that delivery happens smoothly.

At its heart, all of this is still about building tech. It’s driven by integration between EHRs, pharmacies, and delivery data streams, all executed by real-time machine learning models analyzing delivery outcomes like excursions or patient acceptance times.

This is what the real frontier can look like. It’s not just about building smarter AI; it’s about building connected artificial intelligence that unites the entire healthcare system.

That’s what I’ve learned about this problem: how last-mile breakdowns affect patient health and safety, and how designing logistics with clinical-grade standards requires rethinking both software and how it behaves together. Healthcare doesn’t need another dashboard; it needs an invisible infrastructure that patients never have to think about. The most advanced AI right now fails if the drug doesn’t arrive on time, and that’s something we have to change.

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Analyst Predicts ‘Uptober’ Rally for BTC Regardless of FOMC Decision

Analyst Predicts ‘Uptober’ Rally for BTC Regardless of FOMC Decision

The post Analyst Predicts ‘Uptober’ Rally for BTC Regardless of FOMC Decision appeared on BitcoinEthereumNews.com. Bitcoin traded at $116,236 as of 14:04 UTC on Sept. 17, up about 1% in the past 24 hours, holding above a key level as markets await the Federal Reserve’s policy announcement. Analysts’ comments Dean Crypto Trades noted on X that bitcoin is only about 7% above its post-election local peak, while the S&P 500 has risen 9% and gold has surged 36% during the same period. He said bitcoin has compressed more than those assets, making it likely to lead the next larger move, though it could form a “lower high” before extending further. He added that ether could join in once it breaks $5,000 and enters price discovery. Lark Davis pointed to bitcoin’s history around September FOMC meetings, saying every September decision since 2020 — except during the 2022 bear market — has preceded a strong rally. He stressed that the pattern is less about the Fed’s rate choice itself and more about seasonal dynamics, arguing that bitcoin tends to thrive in this period heading into “Uptober.” CoinDesk Research’s technical analysis According to CoinDesk Research’s technical analysis data model, bitcoin rose about 0.9% during the Sept. 16–17 analysis window, climbing from $115,461 to $116,520. BTC reached a session high of $117,317 at 07:00 UTC on Sept. 17 before consolidating. Following that peak, bitcoin tested the $116,400–$116,600 range multiple times, confirming it as a short-term support zone. In the final hour of the session, between 11:39 and 12:38 UTC, BTC attempted a breakout: prices moved narrowly between $116,351 and $116,376 before spiking to $116,551 at 12:34 on higher volume. This confirmed a consolidation-breakout pattern, though the gains were modest. Overall, bitcoin remains firm above $116,000, with support around $116,400 and resistance near $117,300. Latest 24-hour and one-month chart analysis The latest 24-hour CoinDesk Data chart, ending 14:04 UTC on…
Share
BitcoinEthereumNews2025/09/18 12:42
XRP Moves Above $1.40 as Traders Watch Bullish Signals

XRP Moves Above $1.40 as Traders Watch Bullish Signals

The post XRP Moves Above $1.40 as Traders Watch Bullish Signals appeared on BitcoinEthereumNews.com. XRP climbed above $1.40 with $3.5B volume as traders highlight
Share
BitcoinEthereumNews2026/03/14 18:54
Paramount-WBD 2027 movie slate could dominate. Can it sustain?

Paramount-WBD 2027 movie slate could dominate. Can it sustain?

The post Paramount-WBD 2027 movie slate could dominate. Can it sustain? appeared on BitcoinEthereumNews.com. Paramount Skydance CEO David Ellison speaks during
Share
BitcoinEthereumNews2026/03/14 19:06